Document is current
Any future updates will be listed below
-
Authors
Lanteri-Minet, Michel https://orcid.org/0000-0001-6717-9234
Smith, Timothy
Nalpas, Catherine https://orcid.org/0009-0002-2932-0115
Ramirez, Luz M.
Thiry, Alexandra
McCollum, Shannin
Ramaker, Sara https://orcid.org/0009-0004-9639-7918
Fountaine, Robert https://orcid.org/0000-0002-4105-1248
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 9 June 2026
Accepted: 10 September 2026
First Online: 3 October 2026
Declarations
Conflicts of Interest: Michel Lanteri-Minet: Personal fees for consultancy activities from AbbVie/Allergan, Amgen, Eli Lilly, IPSEN, Lundbeck, Novartis, Orion Pharma, Perfood, Pfizer, Reckitt-Benckiser, Teva, and UPSA. Timothy Smith: Personal fees for speakers bureau: AbbVie/Allergan, Amgen, Biohaven, Lilly, and Novartis; advisory boards: AbbVie/Allergan, Alder/Lundbeck, Amgen, Biohaven, Impel Neuropharma, Lilly, Neurolief, Nocira, Nuvie, Teva, Theranica, and Vorso/Nesos; research support: AbbVie/Allergan, Aeon, Alder/Lundbeck, Alnylam, Amgen, Biohaven, Boehringer Ingelheim, Charleston Labs, Electrocore, Graviton, Impel Neuropharma, Lilly, Merz Therapeutics, Nocira, Novartis, Novo Nordisk, Pfizer, Structure Therapeutics, Terns Pharmaceuticals, Teva, Theranica, and Vorso/Nesos. Catherine Nalpas, Luz M Ramirez, Shannin McCollum, and Sara Ramaker: Employees of and hold stock/options in Pfizer. Alexandra Thiry: Former employee of Biohaven Pharmaceuticals, owns stock in Biohaven Ltd, is an employee of Pfizer, and owns stock/options in Pfizer. Robert Fountaine: Former employee of Pfizer (currently retired) and owns stock in Pfizer.
Ethical Approval: The study protocol was approved by an institutional review board/independent ethics committee for each participating site (Supplementary Table 1). All participants provided written informed consent. The study was conducted in compliance with ethical principles of the Declaration of Helsinki and all International Council on Harmonization Good Clinical Practice Guidelines.
